KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Assets (2016 - 2025)

Pfizer (PFE) has disclosed Return on Assets for 17 consecutive years, with 0.0% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets was 0.0% for Q4 2025 at Pfizer, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2021 to a low of 0.0% in Q4 2021.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -3bps in 2021, then changed 0bps in 2022.
  • Pfizer's Return on Assets stood at 0.0% in 2021, then skyrocketed by 102bps to 0.0% in 2022, then crashed by -165bps to 0.0% in 2023, then skyrocketed by 175bps to 0.0% in 2024, then skyrocketed by 275bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for PFE's Return on Assets are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).